TMCnet News

Research and Markets: Cystic Fibrosis Disease Briefing 2015
[May 15, 2015]

Research and Markets: Cystic Fibrosis Disease Briefing 2015


Research and Markets (http://www.researchandmarkets.com/research/2kqfjb/cystic_fibrosis) has announced the addition of the "Cystic Fibrosis Disease Briefing" report to their offering.

The Cystic Fibrosis Disease Briefing provides an overview of the disease and its pathophysiology, including genetic risk factors, and prevalence information with incidence rates for major countries worldwide.

The report includes information on diagnosis, screening and a comprehensive overview of current and emerging treatments, as well as key targets for therapeutic intervention.

A review of morbidity rates and global disease treatment cost information is provided.

Disease Briefings were developed to provide a thorough understanding of the key facts about a disease and its treatment in a quick, easy-to-read format. These manually curated reports are prepared by the editorial team of Thomson (News - Alert) Reuters nd are updated frequently to reflect the latest developments.



Each Disease Briefing provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, its pathophysiology, epidemiology and costs. The reports also provide a review of current diagnosis, prevention and treatment options, approached from a mechanistic standpoint.

The primary sources of data for these reports are current literature and treatment guidelines, supplemented with information from pharmaceutical companies, regulatory bodies and medical organizations. Sources and references are provided.


Key Topics Covered:

1. Facts About Cystic Fibrosis

- Pathophysiology

- Genetics

- Epidemiology

- Morbidity and Mortality

- Cost

2. Diagnosis

- Screening

3. Treatment

- Pharmacotherapy

- - Antibacterial Agents

- - Agents For Improving Mucociliary Clearance

- - - Recombinant Human Deoxyribonuclease

- - - Hypertonic Saline

- - - Mannitol

- - - Docosahexaenoic Acid

- - - Elastase Inhibitors

- - Agents For Improving Pulmonary Inflammation

- - Agents For Improving Cftr Protein Function

- - - Gene Therapy

- - - Drugs Targeting Post-Transcriptional Control

- - - Mechanisms

- Nutritional Management

- Supportive Medical Therapy

- Physical Therapy And Exercise

- Lung Transplantation

4. Targets for Therapeutic Intervention

5. Related Websites

6. Selected Online Publications

7. Cystic Fibrosis Treatment Guidelines

8. Bibliography

For more information visit http://www.researchandmarkets.com/research/2kqfjb/cystic_fibrosis


[ Back To TMCnet.com's Homepage ]